Global Hip Replacement Implants Market

Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Global Hip Replacement Implants Market - Analysis By Type, Surgical Approach, Fixation Approach, By Region, By Country (2022 Edition): Market Insights, Pipeline and Forecast with Impact of COVID-19 (2022-2027)" report has been added to ResearchAndMarkets.com's offering. According to the research report, the Global Hip Replacement Implants Market was valued at USD 6764 Million in the year 2021. Diabetes, obesity, hip disorders such as osteoarthritis, rheumatoid arthritis and joint pains along with the confluence of sedentary lifestyles are some of the factors known to increase the chances of developing hip disease which then requires Hip Replacement Implants or surgeries. An increase in the prevalence of these ailments and lifestyle choices among the masses, coupled with the rising geriatric population, represents one of the key factors driving the market growth.

Furthermore, the leading pharmaceutical companies are focusing on the development of new and innovative product that comes with robot-assisted minimally-invasive surgeries that is likely to cater to a large section of the population through customized implants and provide long-lasting improvements in their hip functionality. This is likely to propel the market for Hip Replacement Implants in the forecast period globally. The COVID-19 pandemic had a negative effect on the overall Hip Replacement Implants market due to widespread surgical restrictions and cancellation of implant procedures resulting in monumental revenue losses for the orthopaedic and medical device companies. However, the market for Hip replacement started recovering and began working rapidly in order to cater to the backlog of postponed surgeries. Therefore, in the coming years, it is estimated that the market for Hip replacement will recover rapidly after the resumption of surgical procedures at full force. Scope of the Report

The report analyses the Hip Implants Market by value (USD Million)

The report presents the analysis Hip Implants market for the historical period of 2017-2021 and the forecast period of 2022-2027.

The report analyses the Hip Implants Market by Type (Total Replacement, Partial Replacement and Hip Resurfacing)

The report analyses the Hip Implants Market by Surgical Approach (Posterolateral Approach, Anterolateral Approach and Direct Anterior Approach)

The report analyses the Hip Implants Market by Fixation Approach (Cementless, Cemented and Hybrid))

The Global Hip Implants Market has been analysed By Region (North America, Europe, Asia Pacific and LAMEA)

The Global Hip Implants Market has been analysed By Country (United States, Canada, Germany, United Kingdom, France, Spain, China, Japan, India and Australia)

The attractiveness of the market has been presented by region, by Type, by Surgical Approach and Fixation Approach

Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

The report tracks competitive developments, strategies, mergers and acquisitions and new product development.

The companies analysed in the report include Zimmer Biomet Holdings Inc., Smith & Nephew Plc., Stryker, Johnson & Johnson (DePuy Synthes), MicroPort Scientific Corporation, Medacta International, Globus Medical, Inc., Conformis, Inc., B. Braun Melsungen AG, Medartis Holding AG

Key Topics Covered: 1. Report scope & Methodology 2. Strategic Recommendations 2.1 Invest in Personalized Implants 2.2 Invest in Structural design optimization 2.3 No mixing of components from different manufacturers 3. Global Hip Implants Replacement Market: Product Outlook 4. Global Hip Implants Replacement Market: Size and Forecast 4.1 Global Hip Implants Market Size, By Value, Year 2017-2027 5. Global Hip Implants Replacement Market Segmentation - By Type, Surgical Approach, By Fixation Approach 5.1 Competitive Scenario of Global Hip Implants Market: By Type 5.1.1 Total Replacement - Market Size and Forecast (2017-2027) 5.1.2 Partial Replacement- Market Size and Forecast (2017-2027) 5.1.3 Hip Resurfacing- Market Size and Forecast (2017-2027) 5.2 Competitive Scenario of Global Hip Implants Market: By Surgical Approach 5.2.1 Posterolateral Approach- Market Size and Forecast (2017-2027) 5.2.2 Anterolateral Approach - Market Size and Forecast (2017-2027) 5.2.3 Direct Anterior Approach - Market Size and Forecast (2017-2027) 5.3 Competitive Scenario of Global Hip Implants Market: By Fixation Approach 5.3.1 Cementless- Market Size and Forecast (2017-2027) 5.3.2 Cemented - Market Size and Forecast (2017-2027) 5.3.3 Hybrid - Market Size and Forecast (2017-2027) 6. Global Hip Implants Replacement Market: Regional Analysis 6.1 Competitive Scenario of Global Hip Implants Market: By Region 7. North America Hip Implants Replacement Market: Segmentation (By Type, By Surgical Approach, By Fixation Approach) 8. Europe Hip Implants Replacement Market: Segmentation (By Type, By Surgical Approach, By Fixation Approach) 9. Asia Pacific Hip Implants Replacement Market: Segmentation (By Type, By Surgical Approach, By Fixation Approach) 10. Global Hip Implants Replacement Market Dynamics 10.1 Drivers 10.2 Restraints 10.3 Trends 11. Market Attractiveness 11.1 Market Attractiveness Chart of Global Hip Implants Market - By Type, 2027 11.2 Market Attractiveness Chart of Global Hip Implants Market - By Surgical Approach, 2027 11.3 Market Attractiveness Chart of Global Hip Implants Market - By Fixation Approach, 2027 11.4 Market Attractiveness Chart of Global Hip Implants Market - By Region, 2027 12. Competitive Landscape 12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers 12.2 Market Share Analysis 13. Company Profiles 13.1 Zimmer Biomet Holdings Inc. 13.2 Smith & Nephew Plc. 13.3 Stryker 13.4 Johnson & Johnson (DePuy Synthes) 13.5 MicroPort Scientific Corporation 13.6 Medacta International 13.7 Globus Medical, Inc. 13.8 Conformis, Inc. 13.9 B. Braun Melsungen AG 13.10 Medartis Holding AG 14. About the Publisher

For more information about this report visit https://www.researchandmarkets.com/r/rz8hgd

Global Hip Replacement Implants Market

The market is unstable. Your portfolio doesn’t need to be.

Retirees and those seeking secure income got two items of very good news this week, though you may only have heard about one. July’s inflation came in below fears (although a debate now rages on what the “real” inflation rate is—more on that below). Meanwhile, your ability to earn a guaranteed rate of return on risk-free investments, regardless of what happens to inflation, actually went up.

John Mackey is bowing out in the battle between CEOs and a new generation entering the workforce, but as he told "Reason," he’s not leaving silently.

On Friday, five of China's biggest state firms announced their exit from Wall Street. More delistings could be on the way as Washington and Beijing remained embroiled in a dispute over audit rules for U.S.-listed Chinese companies.

Inflation is still near multi-decade highs. Mr. Wonderful is using these stocks to fight back.

Rogers knows how to survive — and thrive — in turbulent times.

Many semiconductor stocks slumped this year as investors fretted over concerns about slowing sales of PCs and smartphones, the potential overproduction of chips in response to the global chip shortage, and more conservative enterprise spending in a tougher macro environment. As a result, the Philadelphia Semiconductor Sector index has declined about 24% this year as the S&P 500 retreated just 12%.

SNDL Inc. (NASDAQ: SNDL) ("SNDL" or the "Company") reported its financial and operational results for the second quarter ended June 30, 2022. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. All results for the second quarter of 2021 exclude the subsequent acquisitions of Inner Spirit Holdings ("Spiritleaf") and Alcanna Inc. ("Alcanna"), which closed on July 20, 2021, and March 31, 2022, respectively.

Johnson & Johnson stock is hitting its lowest level since March. Here's where it's a steal of a deal.

The entrepreneur Mark Cuban just took a stand in a debate that's hotly controversial in business circles and Congress.

Inflation has been making headlines all year, and rightly so; it’s at 40-year high levels, driven by sharp increases in the prices of gasoline and diesel fuels. But oil and its various refined products have come down in recent weeks, and so – the July inflation numbers weren’t as bad as had been feared. The overall year-over-year price increase for the month came to 8.5%, still awful, but less than the 8.7% economists had been predicting. Markets these days are rallying in response. Whether this

The S&P 500’s initial surge on Thursday to fresh three-month highs fizzled as the session wore on. The good news for bulls is that this is a Tom Jones rally, as in his famous song: “It’s not unusual.” Specifically, there is nothing superlative about the market’s, notably the Nasdaq’s, resurgence off its mid-June trough, suggests Bespoke Investment Group.

The super investor sees softness. But is sticking to her guns.

Financial planners share how much spouses should be able to comfortably spend from joint income.

Where can you find extremely high-quality dividend stocks with high yields? Starting with this list of Dividend Aristocrats and narrowing it down to the higher-yielding ones can produce truly great dividend stocks. Below, we'll take a look at the three highest yielding Dividend Aristocrats now.

Strong crude oil prices have once again brought investors' attention to energy stocks that have long been underperforming. The West Texas Intermediate crude oil price has largely been above $90 per barrel since the beginning of March. Here are two stocks that have delivered solid dividend growth consistently over the years, irrespective of oil prices.

Retirement planning can be tricky. These retirement planning tips can help you figure out the best way to save smarter if you're in your mid-60s and beyond.

I'm retired and living on Social Security and food stamps. I have all my money in two conservative retirement accounts. I cannot contribute any money to them. I plan on taking distributions in five years. What's the best course of … Continue reading → The post Ask An Advisor: I Live on Social Security and Food Stamps. Can I Protect My Investments in a Down Market? appeared first on SmartAsset Blog.

Tesla has given investors something to look forward to this coming week: a three-for-one stock split. As of the close of trading on Aug. 24, Tesla shareholders will get a “dividend” of two extra shares. The next day, Tesla stock will start trading at the new price—a third of what it used to be.

Profit warnings from Nvidia and Micron have sent a chill through chip stocks, but the long-term opportunity is still intact.